Feed-rate adjustment regulates how quickly nutrients enter the culture, helping control substrate availability during growth. Supplying nutrients at a suitable rate can reduce the likelihood of excess substrate and inhibitory byproduct formation while continuing to support cellular or microbial activity. This balance helps maintain productive conditions and may extend the culture period for biomass or recombinant protein production.
As feed accumulates, the working volume rises, which changes the conditions for oxygen transfer within the bioreactor. The addition rate therefore must be considered alongside the culture’s oxygen-transfer needs, not only its nutrient demand. Managing these linked variables helps sustain growth and productivity as the culture becomes larger during the process.
Batch culture does not provide the same volume increase associated with ongoing feed addition. In Variable Volume Fed-batch, nutrient delivery and working-volume changes can be used to maintain substrate availability over a longer productive period. This strategy may improve biomass or recombinant protein yields compared with batch culture when the process is appropriately controlled.
The process begins with cells or microorganisms growing in a bioreactor, followed by addition of a nutrient-rich feed. As the feed accumulates, the working volume increases, and the addition rate is adjusted in response to substrate availability, byproduct formation, oxygen-transfer conditions, and growth needs. Production then continues under these changing culture conditions.
Researchers may choose this approach when they want to support extended growth or production rather than rely solely on an initial nutrient supply. It is relevant when controlling substrate availability, limiting inhibitory byproduct formation, and sustaining oxygen transfer are important. These goals make the strategy useful for biomass, recombinant protein, enzyme, vaccine, and other biologically derived product production.
Applications span microbial fermentation and mammalian cell culture, so the strategy can support different biological production systems. In these settings, it is used for biopharmaceuticals, enzymes, vaccines, recombinant proteins, and other biologically derived products. Its value lies in coordinating nutrient delivery with growth and production requirements as the culture volume increases.